MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
two doctors, a man and a woman, examine an MRI image of the brain

FDA Decision On Tolebrutinib

MStranslate
January 12, 2026
Clinical Trials
A pair of hands around a crystal ball that has the year 2026 written inside it.

Multiple Sclerosis Research In 2026

MStranslate
January 5, 2026
Progressive MS, Remyelination, Treatments
ECTRIMS Congress 2025

Revisiting ECTRIMS Congress 2025

MStranslate
November 18, 2025
ECTRIMS, Podcasts, Research
The ECTRIMS Podcast

UPDATED: The ECTRIMS Podcast – Episode Library

MStranslate
September 10, 2025
ECTRIMS, Podcasts, Research
Patient Community Day

Patient Community Day at ECTRIMS 2025

MStranslate
July 22, 2025
ECTRIMS, Events, Research
Clinical Trial

MIS416: A Clinical Trial for Secondary Progressive MS

MStranslate
August 26, 2015
Clinical Trials, Research, Treatments
Due to the lack of available treatment options for people with secondary progressive multiple sclerosis (SPMS), the development of novel therapies is vitally important. We sat down with Simon Wilkinson (CEO,...
Fatigue

Fatigue, Melatonin & MS

MStranslate
August 24, 2015
Fatigue, Lifestyle, Research, Symptoms
Fatigue is one of the most common symptoms associated with multiple sclerosis (MS) and is often the one that has the biggest impact on quality of life.  A new study from Dr Lauren Strober, a researcher at...
Human Endogenous Retroviruses

Human Endogenous Retroviruses & MS

MStranslate
August 4, 2015
Collaboration, Research
Dr John Kriesel, head of the Kriesel Lab at the University of Utah, provides an overall introduction to his team.  In particular, he discusses their investigations into the link between human endogenous...
Multiple Sclerosis

Diet and Multiple Sclerosis

MStranslate
July 27, 2015
Diet, Lifestyle, Research
We all know that a healthy diet is important for our well-being, but does it differ for people with multiple sclerosis? As something that can be "controlled", diet is a constant topic of discussion in the MS...
Secretogranin-1

Secretogranin-1: A Potential New Biomarker for MS

MStranslate
July 16, 2015
Research
Recent studies have shown that early administration of therapies lead to better long-term outcomes for people with multiple sclerosis (MS). Therefore, it is of interest to identify methods that enable an early...
Jonathan Kipnis

Lymphatic System in the Brain: Prof Jonathan Kipnis

MStranslate
July 7, 2015
Research
In early June, media outlets across the world featured groundbreaking research undertaken by the Kipnis Lab at the University of Virginia. Published in Nature, this study showed the presence of a lymphatic...
Teisha Rose

Google Hangout featuring Teisha Rose

MStranslate
July 2, 2015
Google Hangouts
On June 25, 2015, we held a Google Hangout with special guest, Teisha Rose, author of the book “Life Interrupted”. Teisha’s book is a very personal insight into her multiple sclerosis journey,...

Announcing Brand New Monday Meet-ups!

MStranslate
June 19, 2015
Events, Google Hangouts
We are pleased to announce that Brett will now be hosting private Google Hangouts every Monday night between 7pm and 8pm. This will be an opportunity to come in and discuss all things related to multiple...
Stem Cell Therapy

Stem Cell Therapy in Multiple Sclerosis

MStranslate
June 18, 2015
Stem Cells, Treatments
A/Prof Helmut Butzkueven from the Melbourne Brain Centre speaks with us to help clear up the confusion surrounding the use of Stem Cell Therapy in multiple sclerosis. He explains how stem cells are currently...

Compound Reduces Neurodegeneration in Mouse Model of MS

MStranslate
June 2, 2015
Research
Researchers from Virginia Commonwealth University and the University of Illinois at Chicago have identified a compound that is able to reduce neurodegeneration in a mouse model of multiple sclerosis. The...
  1. 24
  2. 25
  3. 26
  4. 27
  5. 28
  6. 29
  7. 30

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.